Literature DB >> 28480955

Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden.

Eleni Syrimi1, Sanjeeva Gunasekera1, Alice Norton1, Mark Velangi1, Jayashree Motwani1, Prashant Hiwarkar1.   

Abstract

Entities:  

Keywords:  hyperuricaemia; single dose rasburicase; tumour lysis

Mesh：

Substances：

Year:  2017        PMID： 28480955     DOI： 10.1111/bjh.14689

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.

Authors:  Yuxin Pei; Yu Li; Yujian Liang; Lingling Xu; Xueqiong Huang; Yijuan Li; Wen Tang; Xiaoyun Jiang
Journal:  Int J Clin Pharm       Date:  2020-09-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.